CONFLUENCE LIFE SCIENCES, INC.
SAINT LOUIS, MO · Founded 2010 · CIK 0001540502 · Biotech · Acquired
Selective ITK kinase inhibitor drug candidates for colorectal cancer immunotherapy
confluence.com →- Grants
- $1.0M
- 4 awards
- Sector median: 1
- Raised
- $5.7M
- 2 Form D · Apr 2016
- 126 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 24
- 9 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201220132014201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $895,000 | |
| Private capital raised | Form D · SEC | $4,832,525 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · ITK inhibitors as an immunotherapeutic approach to colorectal cancer | $299,949 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · ITK inhibitors as an immunotherapeutic approach to colorectal cancer | $299,949 | |
| Federal grant | Department of Health and Human Services · Phase I · ITK/TXK Inhibitors as Oral Immunotherapeutic Drugs for Psoriasis | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · ITK TXK Inhibitors as Oral Immunotherapeutic Drugs for Psoriasis | $225,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2504 | GYRE THERAPEUTICS, INC. | — | $5.0M |
| 2505 | VIVOVERSE, LLC | — | — |
| 2506 | Kamau Therapeutics, Inc. | — | $5.0M |
| 2507 | CONFLUENCE LIFE SCIENCES, INC. | — | $5.7M |
| 2508 | Panorama Medicine Inc | — | $4.7M |
| 2509 | GENEDIT INC | — | — |
| 2510 | DUO ONCOLOGY INC | — | $4.2M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Robert BeardsleyExecutive Officer
- Jennifer BohnertExecutive Officer
- Charles BoltenDirector
- Dan BroderickDirector
- Daniel JaniakDirector
- Michael KuoDirector
- Joseph MonahanDirector · Executive Officer
- Kyparissia SirinakisDirector
- Thomas SmartDirector
- Walter SmithDirector · Executive Officer
Patents
- Heterocyclic Itk Inhibitors For Treating Inflammation And Cancergranted
- 4-ALKOXY/ARALKOXY-5-SUBSTITUTED-PYRROLOPYRIMIDINE Compounds As TAK1 Inhibitors In Disease Treatmentgranted
- SUBSTITUTED PYRROLO[2,3-b]PYRIDINES FOR TREATING CANCER OR INFLAMMATORY DISEASESgranted
- Substituted Pyridinone-pyridinyl Compoundsgranted
- Substituted Pyridinone-pyridinyl Compoundsgranted
- Methyl/difluorophenyl-methoxy Substituted Pyridinone-pyridinyl Compounds, Methyl-pyridinyl-methoxy Substituted Pyridinone-pyridinyl Compounds, And Methyl-pyrimidinyl-methoxy Substituted Pyridinone-pyridinyl Compoundsgranted
- Arylpyridinone Itk Inhibitors For Treating Inflammation And Cancerapplication
- Arylpyridinone Itk Inhibitors For Treating Inflammation And Cancergranted
- Methyl/fluoro-pyridinyl-methoxy Substituted Pyridinone-pyridinyl Compounds And Fluoro-pyrimidinyl-methoxy Substituted Pyridinone-pyridinyl Compoundsgranted
- Substituted Pyrimidinone-phenyl-pyrimidinyl Compoundsgranted
- Substituted Pyrimidinone-phenyl-pyrimidinyl Compoundsapplication
- Substituted Pyridine Urea Compoundsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.